The group of Dr. Alex Vahrmeijer is focussing on precision surgery to improve the treatment of cancer patients. In a unique collaboration involving LUMC, CHDR and national and international partners current research focuses on the introduction of real-time tumour detection and normal structure delineation using both clinically available probes and novel tumour specific probes.